Extension to TerugBetaalRegeling Acecort®
Recently also Acecort® 2 and 3 mg tablets have been registered. The health insurer will not reimburse the cost in full. The...
Renewal reimbursement scheme Forxiga® (dapagliflozine) 10 mg and Xigduo (dapagliflozine & metformine HCI) 5 mg
The Reimbursement Solution TerugBetaalRegeling (TBR) of Forxiga® (dapagliflozine) 10 mg and Xigduo (dapagliflozine & metformine...
Termination TerugBetaalRegeling Tecfidera®
As of December 1, 2021, a Personal Contribution for Tecfidera is no longer required. Health insurers will once again fully...
Termination TerugBetaalRegeling Fragmin®2500
From January 1st 2022 onwards, the reimbursement scheme for FRAGMIN (dalteparine)2500 INJVLST 12.500IE/ML WWSP 0,2ML will be...
Reimbursement Scheme Forxiga® (dapagliflozin) 10 mg for patients with diabetes partially stopped
From September 1st 2021 onwards, Forxiga® (dapagliflozin) 10 mg for the treatment of adults with type 2 diabetes mellitus with a...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine